Related Experiment Videos
Does phenobarbital used for febrile seizures cause sleep disturbances?
D G Hirtz1, T C Chen, K B Nelson
1Developmental Neurology Branch, National Institutes of Neurological Disorders and Stroke, NIH, Bethesda, Maryland.
Insights
Phenobarbital did not increase sleep problems for most children with febrile seizures. However, poor sleepers experienced more night awakenings when given phenobarbital.
Area of Science:
- Pediatrics
- Neurology
- Sleep Medicine
Background:
- Febrile seizures are common in young children.
- Phenobarbital is a medication sometimes used for seizure management.
- Sleep disturbances are a potential concern with certain medications.
Purpose of the Study:
- To evaluate the impact of phenobarbital on sleep patterns in children with febrile seizures.
- To determine if phenobarbital affects total sleep time, night awakenings, or lengthy awakenings.
Main Methods:
- A randomized trial involving children aged 8-36 months with febrile seizures.
- Sleep patterns were monitored through parental observation over a 2.5-year period.
- Comparison between phenobarbital and placebo groups.
Main Results:
- No significant difference in total sleep time between phenobarbital and placebo groups.
- Night awakenings were not more frequent in the phenobarbital group overall.
- Children with pre-existing poor sleep habits showed increased night awakenings with phenobarbital.
Conclusions:
- Phenobarbital treatment for febrile seizures did not lead to widespread sleep problems.
- A subgroup of children, particularly those with initial sleep difficulties, may experience increased night awakenings.
- Clinical consideration of sleep impact is warranted for predisposed children.
Abstract:
The effect of phenobarbital on total sleep time, night awakenings, and lengthy awakenings was examined as part of a randomized trial of children with febrile seizures; information about sleep patterns was gathered by parental observation. Children were between ages 8-36 months at enrollment and were examined subsequently for 2 1/2 years. Night awakenings were not more common in children assigned to phenobarbital except for those who were poor sleepers at the beginning of the study. Total sleep time was no different in children assigned to phenobarbital than in those assigned to placebo. It is concluded that sleep problems reported in most young children with febrile seizures treated with phenobarbital did not exceed those reported in children treated with placebo, but a subset of predisposed children did experience an increase in night awakenings.